UNSPSC 51171910: Pancreatin

This classification denotes a gastrointestinal drug and bile, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FQ3DRG0N5K.

UNSPSC 51171910 Pancreatin is a Commodity code that nominally covers pancreatic enzyme supplements, but recent state and local procurement activity under this designation shows little connection to that scope. The most recent opportunities tagged to this code involve offender drug testing services, pharmaceutical direct-to-manufacturer contracting arrangements, and generic multi-source pharmaceutical distribution — none of which align with pancreatin products or their supply. The mismatch suggests either that the code has been applied incorrectly to these opportunities or that the code itself sees minimal relevant activity in state and local procurement.

The source provides three recent state-local opportunities tagged under this code, but none involve pancreatin: Collin County Community Supervision and Corrections Department issued RFP 2026-327 (due July 23, 2026) for offender specimen collection and drug testing services with an estimated contract value of $600,000 over two years; the Texas Health and Human Services Commission issued a Request for Information in April 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative direct-to-manufacturer prescriptions program; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued an RFP (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers including AmerisourceBergen, Cardinal Health, and Morris & Dickson. None of these solicitations reference pancreatin or pancreatic enzyme products as part of their scope.